Immuneering Corporation (IMRX)

Immuneering Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	128.65	36.14	59.41	72.64	74.89
Short-Term Investments	44.19	-	26.26	32.89	74.31
Cash & Short-Term Investments	172.83	36.14	85.67	105.52	149.2
Cash Growth	378.17%	-57.81%	-18.82%	-29.27%	302.26%
Accounts Receivable	-	-	-	0.01	0.25
Other Current Assets	3.41	3.44	3.42	3.21	2.89
Total Current Assets	176.25	39.59	89.08	108.75	152.33
Net Property, Plant & Equipment	4.26	4.79	5.4	5.78	6.13
Other Intangible Assets	0.32	0.35	0.38	0.41	0.44
Goodwill	6.69	6.69	6.69	6.69	6.7
Long-Term Investments	44.18	-	-	-	1
Other Long-Term Assets	0.28	1.3	1.03	0.74	0.1
Total Assets	231.99	52.71	102.58	122.37	166.7
Accounts Payable	1.54	1.96	2.11	3.15	1.39
Accrued Expenses	7.84	4.97	5.17	4.5	3.97
Current Portion of Leases	0.4	0.34	0.3	0.38	0.27
Other Current Liabilities	0.29	0.23	0.26	0.02	-
Total Current Liabilities	10.07	7.5	7.85	8.05	5.63
Long-Term Leases	3.43	3.82	4.16	4.46	5.09
Total Long-Term Liabilities	3.43	3.82	4.16	4.46	5.09
Total Liabilities	13.5	11.33	12.01	12.52	10.72
Common Stock	0.06	0.03	0.03	0.03	0.03
Additional Paid-in Capital	498.66	265.65	253.81	219.64	215.28
Accumulated Other Comprehensive Income	0.08	-	-0	-0.03	-0.05
Retained Earnings	-280.32	-224.3	-163.26	-109.79	-59.27
Total Common Shareholders' Equity	218.48	41.39	90.58	109.85	155.98
Shareholders' Equity	218.48	41.39	90.58	109.85	155.98
Total Liabilities & Equity	231.99	52.71	102.58	122.37	166.7
Total Debt	3.82	4.16	4.46	4.84	5.36
Net Cash (Debt)	169.01	31.98	81.2	100.68	143.83
Net Cash Growth	428.45%	-60.61%	-19.35%	-30.00%	294.40%
Net Cash Per Share	3.84	1.07	2.86	3.82	10.57
Book Value	218.48	41.39	90.58	109.85	155.98
Book Value Per Share	4.96	1.38	3.19	4.16	11.46
Tangible Book Value	211.47	34.35	83.51	102.75	148.84
Tangible Book Value Per Share	4.80	1.15	2.94	3.89	10.93

Updated Mar 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q